HERTRAZ Trastuzumab 150mg & 440mg

DESCRIPTION

HERTRAZ also known as Trastuzumab  is  an anticancer drug used for the treatment of HER2-positive breast cancer (around 25% of all breast cancer). Hertraz is also used to treat certain type of stomach cancer. It can be obtained only with prescription.

Manufacturer : Biocon Limited

ADDITIONAL INFORMATION

Strengths available :  150mg & 440mg Vial

Dosage : 

Hertraz should be administered as intravenous infusion.

Do not administer as an intravenous push or bolus.

Weekly Schedule:  The recommended initial loading dose is 4 mg/kg body weight Hertraz administered as a 90-minute intravenous infusion. Patients should be observed for fever and chills or other infusion-associated symptoms. Interruption of the infusion may help control such symptoms. The infusion may be resumed when symptoms abate.

Subsequent Doses: The recommended weekly dose of Hertraz is 2 mg/kg body weight. If the prior dose was well tolerated, the dose can be administered as a 30-minute infusion.

Patients should be observed for fever and chills or other infusion-associated symptoms.

SIDE EFFECTS

Most common side effects are Dizziness, fever or chills, headache, muscle aches, nausea or vomiting, skin rash, sore throat, stuffy or runny nose, unusual tiredness or weakness.

PACK SIZE

Pack of 1 Vial

 

Reviews

There are no reviews yet.

Be the first to review “HERTRAZ Trastuzumab 150mg & 440mg”

Your email address will not be published. Required fields are marked *